Search results
Altria is a leading tobacco company that offers smoke-free products, such as nicotine pouches and e-vapor devices. Learn about its business strategies, sustainability efforts, community impact and career opportunities.
- About Altria
Altria has a leading portfolio of tobacco products for U.S....
- Moving Beyond Smoking
At Altria, we're Moving Beyond Smoking TM. "In our view,...
- Responsibility
Altria’s tobacco companies are the undisputed market leaders...
- Investors
Altria (MO - NYSE) As of July 23, 2024 2:42 PM ET....
- People & Careers
At the Altria family of companies, we’re not content with...
- Reduce the Harm of Tobacco Products
To achieve our Vision, we are developing a portfolio of...
- Smoke-free Product Platforms
On June 1, 2023, Altria completed its acquisition of NJOY...
- Science, Research & Development
Altria’s scientists, engineers, product developers and...
- About Altria
Altria is the parent company of Philip Morris USA, John Middleton, Inc., U.S. Smokeless Tobacco Company, Inc., and Philip Morris Capital Corporation. Altria also maintains large minority stakes in Belgium-based brewer AB InBev and the Canadian cannabis company Cronos Group.
Find the latest Altria Group, Inc. (MO) stock quote, history, news and other vital information to help you with your stock trading and investing.
Altria has a leading portfolio of tobacco products for U.S. tobacco consumers 21+. Our tobacco companies – which have been the undisputed market leaders in the U.S. tobacco industry for decades – include some of the most enduring names in American business.
Get the latest Altria Group Inc (MO) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Altria is the leader in the U.S. tobacco industry, working to transition adult smokers to smoke-free alternatives and pursue new opportunities beyond nicotine. Learn about its Purpose, Vision, Goals, Responsibility Focus and Cultural Aspiration.
Apr 30, 2024 · Altria to receive cash payments from Philip Morris International of approximately $2.7 billion in exchange for assigning exclusive U.S. commercialization rights to the IQOS system effective April 30, 2024. Altria gains greater flexibility to allocate resources toward Moving Beyond Smoking .